| Financial Year |
March 31 2023 |
| Monetary Funds |
45,884,713.20 |
| Held-for-trading Financial Assets |
267,088,824.62 |
| Notes Receivable |
33,115.50 |
| Accounts Receivable |
267,547,055.07 |
| Advances to Suppliers |
2,845,575.35 |
| Other Receivables |
6,251,644.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
110,850,293.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
700,501,221.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,576,780.21 |
| Investment Properties |
-- |
| Fixed Assetes |
668,049,453.57 |
| Under-construction Projects |
103,180,554.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,289,507.31 |
| R&D expenses |
44,663,279.24 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
6,778,498.88 |
| Other Non-Current Assets |
21,557,350.00 |
| Sub-Total of Non-Current Assets |
899,669,144.16 |
| Total Assets |
1,600,170,365.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
7,234,974.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,352,925.17 |
| Taxes Payable |
9,468,035.65 |
| Interest Payable |
-- |
| Dividend Payable |
441,098.70 |
| Other payables |
34,578,805.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
348,556.52 |
| Other Current Liabilities |
11,629,654.05 |
| Sub-Total of Current Liabilities |
75,181,412.66 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
669,381.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,886,624.90 |
| Total Liabilities |
87,068,037.56 |
| Paid-In Capital(Or Share Stock) |
410,644,000.00 |
| Capital Surplus |
546,403,106.25 |
| Surplus Reserve |
71,619,070.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
484,436,151.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,513,102,327.86 |
| Owner's Equity（Stockholder's Equity） |
1,513,102,327.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,600,170,365.42 |
